- Home
- DFDV vs HRTX Comparison
DFDV vs HRTX Comparison
Compare DFDV & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DFDV
- HRTX
- Stock Information
- Founded
- DFDV 2018
- HRTX 1983
- Country
- DFDV United States
- HRTX United States
- Employees
- DFDV N/A
- HRTX N/A
- Industry
- DFDV Finance: Consumer Services
- HRTX Biotechnology: Pharmaceutical Preparations
- Sector
- DFDV Finance
- HRTX Health Care
- Exchange
- DFDV Nasdaq
- HRTX Nasdaq
- Market Cap
- DFDV 340.7M
- HRTX 325.0M
- IPO Year
- DFDV N/A
- HRTX 1987
- Fundamental
- Price
- DFDV $24.35
- HRTX $1.96
- Analyst Decision
- DFDV Buy
- HRTX Strong Buy
- Analyst Count
- DFDV 1
- HRTX 2
- Target Price
- DFDV $45.00
- HRTX $5.00
- AVG Volume (30 Days)
- DFDV 2.3M
- HRTX 1.4M
- Earning Date
- DFDV 07-29-2025
- HRTX 08-05-2025
- Dividend Yield
- DFDV N/A
- HRTX N/A
- EPS Growth
- DFDV N/A
- HRTX N/A
- EPS
- DFDV N/A
- HRTX N/A
- Revenue
- DFDV $1,975,695.00
- HRTX $148,518,000.00
- Revenue This Year
- DFDV $70.03
- HRTX $12.08
- Revenue Next Year
- DFDV $142.86
- HRTX $12.57
- P/E Ratio
- DFDV N/A
- HRTX N/A
- Revenue Growth
- DFDV 1.47
- HRTX 12.43
- 52 Week Low
- DFDV $0.48
- HRTX $1.04
- 52 Week High
- DFDV $53.88
- HRTX $3.53
- Technical
- Relative Strength Index (RSI)
- DFDV N/A
- HRTX 44.03
- Support Level
- DFDV N/A
- HRTX $1.99
- Resistance Level
- DFDV N/A
- HRTX $2.28
- Average True Range (ATR)
- DFDV 0.00
- HRTX 0.10
- MACD
- DFDV 0.00
- HRTX -0.02
- Stochastic Oscillator
- DFDV 0.00
- HRTX 9.68
About DFDV DeFi Development Corp. Common Stock
DeFi Development Corp is an AI-powered online platform that connects the commercial real estate industry by providing data and software subscriptions as well as value-add services to multifamily and commercial property professionals.
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.